P

Active Director Director DIN 09573842
DIN 09573842 First appointment May 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Priyanka

Data last updated:

Priyanka is a Director at Nervet Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Nervet Pharmaceuticals Private Limited reported revenue of ₹65,820 (FY 2024).

DIN 09573842
Primary Designation Director
Industry Chemicals
First Appointment 12 May 2022
Oldest Company Age 4 yrs
Largest company Nervet Pharmaceuticals Private Limited · ₹65,820 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 May 20222022₹65,820 (FY 2024)Active

Board colleagues of Priyanka

NameDINCompanyDesignation
Subodh Kumar Pandey09573869Nervet Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nervet Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priyanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka

Priyanka currently holds 1 directorship: Nervet Pharmaceuticals Private Limited (Director, since 12 May 2022, revenue ₹65,820 (FY 2024)).

Priyanka was first appointed on 12 May 2022 as Director at Nervet Pharmaceuticals Private Limited.

The current boards of Priyanka's companies include Subodh Kumar Pandey (Nervet Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available